Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $346.17 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $125.86 | 2 | $0 (2020) |
| PFIZER INC. | $68.42 | 4 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $46.22 | 3 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $36.97 | 1 | $0 (2023) |
| Mallinckrodt LLC | $24.64 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $22.19 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.87 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $36.97 | 1 | Mallinckrodt Hospital Products Inc. ($36.97) |
| 2020 | $109.37 | 1 | Janssen Pharmaceuticals, Inc ($109.37) |
| 2019 | $136.51 | 8 | PFIZER INC. ($68.42) |
| 2018 | $38.68 | 2 | E.R. Squibb & Sons, L.L.C. ($22.19) |
| 2017 | $24.64 | 1 | Mallinckrodt LLC ($24.64) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/07/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $36.97 | General |
| Category: IMMUNOLOGY | ||||||
| 01/16/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $109.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/25/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/13/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/26/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/21/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.87 | General |
| 02/14/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/30/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/03/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: Cardiovascular | ||||||
| 01/19/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/30/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: ACUTE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 56 | 73 | $18,247 | $5,974 |
| 2022 | 4 | 93 | 141 | $27,402 | $11,455 |
| 2021 | 1 | 29 | 55 | $7,443 | $3,555 |
| 2020 | 9 | 626 | 1,480 | $666,497 | $128,489 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 51 | $10,404 | $3,578 | 34.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,169 | $1,265 | 30.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $3,674 | $1,132 | 30.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 85 | $12,560 | $5,345 | 42.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $5,752 | $2,439 | 42.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 25 | $5,390 | $2,166 | 40.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 17 | 17 | $3,701 | $1,505 | 40.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 55 | $7,443 | $3,555 | 47.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 185 | 535 | $225,802 | $45,405 | 20.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 110 | 515 | $181,795 | $33,162 | 18.2% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 92 | 96 | $73,419 | $14,700 | 20.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 74 | 151 | $76,406 | $14,097 | 18.5% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 63 | 79 | $49,059 | $9,861 | 20.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 21 | $20,554 | $3,741 | 18.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 35 | 36 | $19,188 | $3,492 | 18.2% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2020 | 31 | 31 | $15,004 | $3,011 | 20.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 15 | 16 | $5,270 | $1,020 | 19.4% |
About Dr. Constance Wong, MD
Dr. Constance Wong, MD is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1730356882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Constance Wong, MD has received a total of $346.17 in payments from pharmaceutical and medical device companies, with $36.97 received in 2023. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($346.17).
As a Medicare-enrolled provider, Wong has provided services to 804 Medicare beneficiaries, totaling 1,749 services with total Medicare billing of $149,475. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Daly City, CA
- Active Since 05/08/2008
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730356882
Products in Payments
- INVOKANA (Drug) $109.37
- ELIQUIS (Drug) $76.86
- ZERBAXA (Drug) $46.22
- ACTHAR (Biological) $36.97
- OFIRMEV (Drug) $24.64
- XARELTO (Drug) $16.49
- CHANTIX (Drug) $13.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Daly City
Kevin Wong, M.d, M.D
Internal Medicine — Payments: $45,517
Tony Wong, M.d, M.D
Internal Medicine — Payments: $40,235
Dr. John Lai, M.d, M.D
Internal Medicine — Payments: $39,667
Dr. Alice Yan, M.d, M.D
Internal Medicine — Payments: $22,968
Damon Lee, Md, MD
Internal Medicine — Payments: $20,608
Dr. Shu May Lee, M.d, M.D
Internal Medicine — Payments: $18,620